Last reviewed · How we verify
Matching placebo rectal foam
A placebo rectal foam formulation used as a control comparator in clinical trials.
At a glance
| Generic name | Matching placebo rectal foam |
|---|---|
| Sponsor | Bausch Health Americas, Inc. |
| Modality | Small molecule |
| Phase | FDA-approved |
Mechanism of action
Matching placebo rectal foam is an inert formulation designed to match the physical and sensory characteristics of an active rectal foam therapeutic agent, allowing for blinded clinical trial comparisons. It contains no active pharmaceutical ingredient and serves solely as a control to assess the efficacy and safety of the active treatment through placebo-controlled study design.
Approved indications
Common side effects
Key clinical trials
- Dose Ranging Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Rectal Foam in Pediatric Patients Aged 5 to 17 Years With Active, Mild to Moderate Distal Ulcerative Colitis (PHASE4)
- Efficacy and Safety of Budesonide Foam for Participants With Active Mild to Moderate Ulcerative Proctitis or Proctosigmoiditis (PHASE3)
- Efficacy and Safety of Budesonide Foam for Participants With Active Mild to Moderate Ulcerative Proctitis or Proctosigmoiditis (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Matching placebo rectal foam CI brief — competitive landscape report
- Matching placebo rectal foam updates RSS · CI watch RSS
- Bausch Health Americas, Inc. portfolio CI